Allison E Aiello1, Hoang-Oanh T Nguyen, Mary N Haan. 1. Dept. of Epidemiology, Center for Social Epidemiology and Population Health, University of Michigan School of Public Health, 3659 SPH Tower, 109 Observatory, Ann Arbor, MI 48109-2029, USA. aielloa@umich.edu
Abstract
BACKGROUND: Although the apolipoprotein (APOE)-epsilon4 allele has been shown to determine the outcome of several infections, its relationship with cytomegalovirus (CMV) has not been explored. We examine whether APOE determines CMV and herpes simplex virus type 1 (HSV-1) antibody levels and assess whether C-reactive protein (CRP) mediates any observed relationships. METHODS: We conducted a cross-sectional analysis of a randomly selected subset (n = 1561/1789) of participants aged 60-101 in the Sacramento Area Latino Study on Aging. Blood samples were tested for APOE genotype, CRP, and immunoglobulin G antibodies to CMV and HSV-1. Multivariate logistic regression was used to examine the association between epsilon4 and CMV and HSV antibody levels. We also assessed whether CRP mediates the effects of any observed associations between epsilon4 and viral antibody levels. RESULTS: CMV antibody and CRP levels varied significantly by APOE genotype. The association between CRP and CMV antibody was strengthened in the presence of epsilon4. In contrast, this effect was not observed in HSV-1. We found that APOE-epsilon4 carriers had significantly lower levels of CRP yet significantly higher levels of CMV antibodies, suggesting a mediating pathway. CONCLUSIONS: APOE-epsilon4 carriers may experience immunological aberrations that lead to lower levels of CRP and correspondingly higher CMV antibody levels.
BACKGROUND: Although the apolipoprotein (APOE)-epsilon4 allele has been shown to determine the outcome of several infections, its relationship with cytomegalovirus (CMV) has not been explored. We examine whether APOE determines CMV and herpes simplex virus type 1 (HSV-1) antibody levels and assess whether C-reactive protein (CRP) mediates any observed relationships. METHODS: We conducted a cross-sectional analysis of a randomly selected subset (n = 1561/1789) of participants aged 60-101 in the Sacramento Area Latino Study on Aging. Blood samples were tested for APOE genotype, CRP, and immunoglobulin G antibodies to CMV and HSV-1. Multivariate logistic regression was used to examine the association between epsilon4 and CMV and HSV antibody levels. We also assessed whether CRP mediates the effects of any observed associations between epsilon4 and viral antibody levels. RESULTS: CMV antibody and CRP levels varied significantly by APOE genotype. The association between CRP and CMV antibody was strengthened in the presence of epsilon4. In contrast, this effect was not observed in HSV-1. We found that APOE-epsilon4 carriers had significantly lower levels of CRP yet significantly higher levels of CMV antibodies, suggesting a mediating pathway. CONCLUSIONS:APOE-epsilon4 carriers may experience immunological aberrations that lead to lower levels of CRP and correspondingly higher CMV antibody levels.
Authors: Sarinnapha Vasunilashorn; Caleb E Finch; Eileen M Crimmins; Suvi A Vikman; Jonathan Stieglitz; Michael Gurven; Hillard Kaplan; Hooman Allayee Journal: Biodemography Soc Biol Date: 2011
Authors: Lisa L Barnes; Ana W Capuano; Alison E Aiello; Arlener D Turner; Robert H Yolken; E Fuller Torrey; David A Bennett Journal: J Infect Dis Date: 2014-08-08 Impact factor: 5.226
Authors: Jonathan M Kocarnik; Sarah A Pendergrass; Cara L Carty; James S Pankow; Fredrick R Schumacher; Iona Cheng; Peter Durda; José Luis Ambite; Ewa Deelman; Nancy R Cook; Simin Liu; Jean Wactawski-Wende; Carolyn Hutter; Kristin Brown-Gentry; Sarah Wilson; Lyle G Best; Nathan Pankratz; Ching-Ping Hong; Shelley A Cole; V Saroja Voruganti; Petra Bůžkova; Neal W Jorgensen; Nancy S Jenny; Lynne R Wilkens; Christopher A Haiman; Laurence N Kolonel; Andrea Lacroix; Kari North; Rebecca Jackson; Loic Le Marchand; Lucia A Hindorff; Dana C Crawford; Myron Gross; Ulrike Peters Journal: Circ Cardiovasc Genet Date: 2014-03-12
Authors: Shawnita Sealy-Jefferson; Brenda W Gillespie; Allison E Aiello; Mary N Haan; Lewis B Morgenstern; Lynda D Lisabeth Journal: PLoS One Date: 2013-06-14 Impact factor: 3.240
Authors: Gabriel Westman; David Berglund; Johan Widén; Martin Ingelsson; Olle Korsgren; Lars Lannfelt; Dag Sehlin; Anna-Karin Lidehall; Britt-Marie Eriksson Journal: PLoS One Date: 2014-05-07 Impact factor: 3.240